Search clinical trials for: Somatostatin Analog

Total 1488 results

Novartis Pharmaceuticals

Not yet recruiting

NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.

Metastatic Neuroendocrine Prostate Cancer
Australasian Gastro-Intestinal Trials Group
Canadian Cancer Trials Group

Not yet recruiting

Cessation of Somatostatin Analogues After PRRT in Mid-Gut Neuroendocrine Tumours (STOPNET)

Neuroendocrine Tumors

Australia
University of Copenhagen
Bispebjerg Hospital

Not yet recruiting

Direct Versus Indirect Effect of Amino Acids on Hepatokines (Diaakine)

Obesity | Non-Alcoholic Fatty Liver Disease

Denmark
University Hospital, Antwerp
Erasmus Medical Center; ZonMw: The Netherlands Organisation for Health Research... and other collaborators

Recruiting

Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients (SAUNA)

Gastroenteropancreatic Neuroendocrine Tumor

Netherlands, Belgium
University Hospital, Strasbourg, France

Recruiting

Somatostatin Analogues in the Treatment of Relapsing GH Pituitary Adenomas After Surgery (STOP-SST)

Acromegaly

France
University Hospital, Bordeaux
Advanced Accelerator Applications

Recruiting

Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases (LUTARTERIAL)

Neuroendocrine Tumor | Liver Metastases | Neuroendocrine Gastroenteropancreatic Tumour

France
Asan Medical Center
Samsung Medical Center; Seoul St. Mary's Hospital; Seoul National University... and other collaborators

Recruiting

Asian Investigation of Lanreotide Autogel® in the Management of GEP-NETs (AIM-NETs)

Neuroendocrine Tumors

Korea, Republic of
University of Roma La Sapienza

Recruiting

Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN) (REBORN)

Neuroendocrine Tumors | Neuroendocrine Carcinoma | Neuroendocrine Neoplasm | Neuroendocrine Tumor Grade 2 | Neuroendocrine Tumor Grade 1

Italy
Radiomedix, Inc.
Orano Med LLC

Recruiting

Phase 1 Study of AlphaMedix™ in Adult Subjects With SSTR (+) NET

Neuroendocrine Tumor

United States
Medical University of Vienna

Not yet recruiting

Non-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO Treatment (SANO)

Pancreatic Neuroendocrine Tumors in MEN1
Sheba Medical Center

Completed

Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy

Congenital Hyperinsulinism

Israel
Mayo Clinic

Enrolling by invitation

Somatostatin Analogues With Perioperative Antibiotics Versus Prolonged Antibiotics

Pancreatic Diseases

United States
Dana-Farber Cancer Institute
Eli Lilly and Company

Active, not recruiting

A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors

Carcinoid Tumors

United States
Jagiellonian University
Medical University of Warsaw

Completed

Clinical Application of the Prototype J-PET Device (JPETClinic)

Neurodegenerative Diseases | Brain Neoplasms | Neuroendocrine Tumors

Poland
SCRI Development Innovations, LLC
Ipsen

Terminated

Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres

Gastrointestinal Neoplasms | Neuroendocrine Tumors | Carcinoid Tumors

United States
Radboud University Medical Center
University Medical Center Groningen; Catharina Ziekenhuis Eindhoven; St. Antonius... and other collaborators

Completed

Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias (OCEAN)

Anemia | Vascular Malformations | Gastrointestinal Hemorrhage | Angiodysplasia

Netherlands
Ipsen

Withdrawn

Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromegaly in China

Acromegaly
General Hospital of Shenyang Military Region

Completed

Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis

Liver Cirrhosis | Hemorrhage | Venous Thrombosis | Varicose Veins | Portal Vein

China
Universitaire Ziekenhuizen KU Leuven
Ipsen

Completed

SOMATULINE Autogel 90 mg IN DUMPING SYNDROME

Dumping Syndrome

Belgium
University Hospital, Ghent
Pfizer

Completed

Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?

Acromegaly

Belgium
Chiasma, Inc.

Completed

Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly (MPOWERED)

Acromegaly

United States, Spain, Hungary, France, United Kingdom, Austria, Germany, Italy, Lithuania, Poland, Romania, Russian Federation, Serbia
Hospices Civils de Lyon

Completed

Reduction by Pasireotide of the Effluent Volume in High-output Enterostomy in Patients Refractory to Usual Medical Treatment (SOMILEO)

Enterostomy

France
Assistance Publique - Hôpitaux de Paris

Completed

Prevention of Postoperative Pancreatic Fistula by Somatostatin (PREFIPS)

Pancreatic Surgery

France
Novartis Pharmaceuticals

Completed

Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease

Acromegaly | Carcinoid Tumor

Germany, Belgium, Canada, Netherlands, United States, Norway
Ipsen

Completed

Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel (SALSA)

Acromegaly

United States
University of Aarhus

Unknown

Fatigue and Quality of Life in Patients With Neuroendocrine Neoplasia

Neuroendocrine Tumors (NET) Health Related Qualito of Life (HRQoL)

Denmark
National Cancer Institute, Naples

Completed

Octreotide LAR in the Induction of Immunologic Response in NENs Patients (CSMS99)

Neuroendocrine Tumors

Italy
Ipsen

Completed

Quality of Life, Treatment Experience and Cost of Treatment With Somatostatin Analogues in Patients With Gastroenteropancreatic Neuroendocrine Tumours (STREET)

Gastroenteropancreatic Neuroendocrine Tumours

Sweden
Mayo Clinic

Completed

Pasireotide LAR in Severe Polycystic Liver Disease (SOM230)

Autosomal Dominant Polycystic Kidney Disease | Polycystic Liver Disease | Autosomal Dominant Polycystic Liver Disease | Somatostatin Analogs

United States
Ipsen

Terminated

Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome

Malignant Carcinoid Syndrome

United States
Istituto Scientifico Romagnolo per lo Studio e...

Unknown

Optimizing the Interval Between Cycles of PRRT With 177lu-dotatate in sstr2 Positive Tumors (LUTHREE)

Neuroendocrine Tumors

Italy
European Organisation for Research and Treatment...
Ipsen

Withdrawn

Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome (TELEFIRST)

Small Intestinal NET | Carcinoid Heart Disease
Novartis Pharmaceuticals

Completed

Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues

Acromegaly

Italy, Belgium, United Kingdom, Bulgaria, Turkey, France, Portugal, China, Argentina, Brazil, Colombia, Hungary, Malaysia, Mexico, Romania
University of Aarhus
Region MidtJylland Denmark

Completed

Etiology, Assessment and Treatment of Post-gastric Bypass Severe Hypoglycemia

Obesity | Hypoglycemia | Surgery

Denmark
Al-Azhar University

Unknown

Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer

Skin Diseases | Breast Cancer | Skin Cancer

Egypt, Saudi Arabia
Ahmed A. H. Abdellatif

Unknown

Targeted Polymeric Nanoparticles Loaded With Cetuximab and Decorated With Somatostatin Analogue to Colon Cancer

Colon Cancer | Colo-rectal Cancer

Egypt, Saudi Arabia
National Cancer Institute (NCI)

Completed

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Uterine Carcinosarcoma | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Endometrial Serous Adenocarcinoma | Lung Carcinoid Tumor | Metastatic... and other conditions

United States, Canada
Peking Union Medical College Hospital

Unknown

Recurrence Rates of Type I Gastric Neuroendocrine Tumors Treated With Long-acting Somatostatin Analogs

Gastric NET

China
Ipsen

Completed

Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery (ESPORA)

Acromegaly

Spain
King Faisal Specialist Hospital & Research Center

Unknown

Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin Analogue

Neuroendocrine Tumors

Saudi Arabia
Lexicon Pharmaceuticals

Completed

TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome)

Carcinoid Syndrome

United States, Australia, Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, Canada, Israel
University Hospital, Grenoble

Completed

Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine Analogues (PHRC-Merkel)

Carcinoma, Merkel Cell

France
Chiasma, Inc.

Completed

Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly

Acromegaly

United States, Netherlands, Italy, Serbia, Hungary, Germany, Lithuania, Mexico, Poland, Romania, Slovakia, Slovenia, United Kingdom
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly

Acromegaly

United States, Germany, Italy, Belgium, Taiwan, Turkey, Switzerland, Israel, Netherlands, Sweden, United Kingdom, Korea, Republic of, Spain, France, Canada, Greece, Russian Federation, Denmark, Mexico, China, Hungary, Norway, Argentina and more
University of Aarhus
Odense University Hospital; Aarhus University Hospital; Herlev Hospital; Aalborg... and other collaborators

Completed

Treatment of Acromegaly With Somatostatin Analogs: GH vs. IGF-I as Primary Biochemical Target

Acromegaly

Denmark
National University Hospital, Singapore

Unknown

Evaluation of PET/MRI Using a Somatostatin Analog Tracer as a Novel Approach to Detecting Pathology in High Risk TB-exposed Contacts

Tuberculosis, Pulmonary

Singapore
Erasmus Medical Center
Novartis

Unknown

Pasireotide LAR and Pegvisomant Study in Acromegaly (PAPE)

Acromegaly

Netherlands
Italfarmaco

Completed

Phase II Study With ITF2984 in Acromegalic Patients (POC)

Acromegaly

France, Hungary, Netherlands, Serbia, Czech Republic, Italy, Spain, Poland, Romania
National Cancer Institute, Naples
Federico II University; University of Campania "Luigi Vanvitelli"

Terminated

Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors (LOTUS)

Neuroendocrine Tumors

Italy
University of Aarhus

Completed

Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects

Metabolic Diseases | Acromegaly

Denmark

Search clinical trials for: Somatostatin Analog

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations